휴마시스

205470KOSDAQ의료용품 및 기타 의약 관련제품 제조업

61.3 / 100

Reference Date: 2026-07-24

Financial Score28.5 / 40

News Sentiment16.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HumaSys operates in three main business segments: POCT immunoassay reagents for in vitro diagnostics, production of male condoms and medical devices, and entertainment services. The POCT division focuses on improving diagnostic products for COVID-19 and HIV, while the rubber products division produces a range of items according to international standards. The entertainment division generates revenue through artist management and content production. Major revenue streams come from POCT (13.4%), rubber products (19.5%), and entertainment services (46.2%).

Number of Employees

64people

Average Salary

47.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.184.0Point

PBR

0.22Industry Average 1.097.0Point

Half of industry avg (excellent)

ROE

-8.97Industry Average -4.893.5Point

1.8x industry avg (good)

Debt Ratio

0.35Industry Average 6.868.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲51.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.2% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 2Neutral 2Negative 1Average Sentiment Score 67

Neutral
“시장 퇴출 피하자”… ‘동전주 탈출’ 안간힘 쓰는 제약·바이오 업.....
휴마시스를 포함한 제약·바이오 기업들이 주가 하락으로 인한 상장폐지 위험을 피하기 위해 액면병합을 추진하고 있으나, 직접적인 영향은 제한적임.
Neutral
남궁견 전 회장·김성곤 전 대표, 휴마시스 주주 A씨 무고·허위사실 ....
Legal dispute involving former executives against a shareholder does not directly impact the company's financial performance or market position.
Negative
휴마시스 전 경영진, 주주 상대 형사고소…"무고·명예훼손" 주장
전 경영진의 형사고소로 인해 휴마시스의 신뢰도 하락과 불확실성이 증가했다.

Detailed Momentum

52-week position3.0Point

52w lower range (39%)

Current 2,115Won52-week high 4,26552-week low 682

1-month return2.0Point

1m -6.00% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-10